Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02978872 · ClinicalTrials.gov registry record
Quantra Determination of Coagulation Parameters in Arterial and Venous Blood
A clinical trial, sponsored by HemoSonics.
- Completed
- Registry status
- 30
- Enrollment target
NCT02978872 is a clinical trial that has completed, run by HemoSonics. The registered enrollment target is 30 participants.
The verdict
NCT02978872 has completed, sponsored by HemoSonics.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02978872
The ClinicalTrials.gov registry entry for NCT02978872 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HemoSonics, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02978872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02978872 about?
NCT02978872 is a clinical study titled "Quantra Determination of Coagulation Parameters in Arterial and Venous Blood". The Quantra™ System is a novel point-of-care diagnostic device designed to perform whole blood coagulation analysis. This study compares Quantra measurements determined in arterial versus venous blood samples obtained from patients undergoing cardiac surgery.
What is the current status of trial NCT02978872?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2016-07. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT02978872?
This trial is sponsored by HemoSonics, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.